Webull Malaysia Launches US Options Trading for Retail Investors with 50% off on US stock trading commission fees

KUALA LUMPUR,Malaysia,Jan. 24,2025--Webull Securities (Malaysia) Sdn. Bhd. ("Webull Malaysia"),a subsidiary of Webull Corporation,a leading digital investment platform,today announced the l

Coffee

Jan 26, 2025

Trip.com Group at the World Economic Forum calls for stronger private and public sector collaboration to counter "unbalanced tourism" and drive growth

DAVOS,Switzerland,Jan. 24,2025--Leading global travel services provider Trip.com Group has called for public and private stakeholders to step up collaboration to unlock new growth potential for the g

Coffee

Jan 26, 2025

Bright Scholar Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2025

SG&A expenses from continuing operationsdecreased 33.0% YoY Management to hold a conference call today at 7:00 a.m. Eastern Time

Coffee

Jan 26, 2025

Global Times: Your hope, our hope: Xi says people can always count on Party, government in difficult times

BEIJING,Jan. 24,2025-- "In just one day,it rained as much as it does in a whole year!" On August 20,2024,an extremely rare and intense rainfall led to a severe flood disaster in Huludao,Nort

Coffee

Jan 26, 2025

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

LONDON,Jan. 25,2025-- Following the licensing agreement with X4 Pharmaceuticals,Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavor

Coffee

Jan 26, 2025

Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer

SYDNEY,Jan. 24,2025-- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"),a clinical-stage radiopharmaceutical company with a mission to develop next-generation products t

Coffee

Jan 26, 2025

Coffee

Webull Malaysia Launches US Options Trading for Retail Investors with 50% off on US stock trading commission fees

Trip.com Group at the World Economic Forum calls for stronger private and public sector collaboration to counter &quot;unbalanced tourism&quot; and drive growth

Bright Scholar Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2025

Global Times: Your hope, our hope: Xi says people can always count on Party, government in difficult times

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer

Trip.com Group at the World Economic Forum calls for stronger private and public sector collaboration to counter "unbalanced tourism" and drive growth